百威亞太(01876.HK)午後升幅曾擴至逾7% 首三季多賺8.7%
恆指現報15,554,續彈237點或1.5%,總成交額僅865億元。
藍籌百威亞太(01876.HK)首三季多賺8.7%,該股繼昨天扭五連跌由上市低位反彈及半日市高收後,下午曾進一步挑戰10天線(17.89元),最多漲7.1%高見18元,現報17.66元,續升5.1%,成交續增至1,488萬股。
百威公布首三季純利按年升8.7%至9.25億美元(下同),總收入按年微跌0.9%至53.13億美元,總銷量按年升1.4%至72.72億公升,主要受惠南韓及印度強勁表現部分抵消內地疫情管控措施影響;毛利率按年跌3.5個百分點至50.9%。期內,百威於中國產品銷量及收入按年分別跌2.2%及1.5%。然而,單計第三季純利按年減近14%至3億美元,收入按年跌1.2%至18.6億元,銷量按年則升6.3%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.